Tadanori Morikawa
-
- Protease and Inhibitor Mechanisms 8
-
- Neuropeptides and Animal Physiology 6
- Organic Chemistry top 10%
- Synthesis of β-Lactam Compounds 3
-
- Chemical Synthesis and Analysis 9
- Protein Hydrolysis and Bioactive Peptides 4
- Receptor Mechanisms and Signaling 4
- Signaling Pathways in Disease 3
-
- Peptidase Inhibition and Analysis 8
- Co-authors
- Shumpei SakakibaraShinjiro OdakeKyoichi KobashiLeena TudermanDarwin J. ProckopTerutoshi KimuraM. OtaniTakanori Noda
- Journals
- Biochemistry (2 papers)Biochemical and Biophysical Research Communications (2 papers)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- Japan
In The Last Decade
Tadanori Morikawa
34 papers receiving 604 citations
Peers
Comparison fields: 5 of 100
- Cancer Research 106
- Cellular and Molecular Neuroscience 108
- Organic Chemistry 160
- Immunology and Allergy 28
- Molecular Biology 304
Countries citing papers authored by Tadanori Morikawa
This map shows the geographic impact of Tadanori Morikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadanori Morikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadanori Morikawa more than expected).
Fields of papers citing papers by Tadanori Morikawa
This network shows the impact of papers produced by Tadanori Morikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadanori Morikawa. The network helps show where Tadanori Morikawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tadanori Morikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 41 | |
| 2 | 1997 | 5 | |
| 3 | Anticoagulant activity of the novel thrombin inhibitor 1-butyl-3-(6,7-dimethoxy-2-naphthylsulfonyl) amino-3-(3-guanidinopropyl)-2-pyrrolidinone hydrochloride. | 1997 | 1 |
| 4 | Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid. | 1997 | 0 |
| 5 | 1996 | 8 | |
| 6 | 1996 | 3 | |
| 7 | 1995 | 3 | |
| 8 | 1995 | 5 | |
| 9 | 1994 | 60 | |
| 10 | 1994 | 65 | |
| 11 | 1994 | 13 | |
| 12 | 1994 | 6 | |
| 13 | 1992 | 26 | |
| 14 | 1992 | 1 | |
| 15 | 1990 | 3 | |
| 16 | 1990 | 5 | |
| 17 | A NOVEL TYPE OF SULFOTRANSFERASE FROM A HUMAN INTESTINAL BACTERIUM, EUBACTERIUM A-44,AND ITS BIOTECHNOLOGICAL APPLICATION | 1987 | 1 |
| 18 | 1982 | 51 | |
| 19 | 1980 | 29 | |
| 20 | 1969 | 22 |
About Tadanori Morikawa
Tadanori Morikawa is a scholar working on Cancer Research, Cellular and Molecular Neuroscience and Organic Chemistry, having authored 35 papers that have together received 640 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (9 papers), Peptidase Inhibition and Analysis (8 papers), Protease and Inhibitor Mechanisms (8 papers), Neuropeptides and Animal Physiology (6 papers), Protein Hydrolysis and Bioactive Peptides (4 papers), Receptor Mechanisms and Signaling (4 papers), Signaling Pathways in Disease (3 papers) and Synthesis of β-Lactam Compounds (3 papers). The work is most often cited by research in Cancer Research (106 citations), Cellular and Molecular Neuroscience (108 citations) and Organic Chemistry (160 citations). Tadanori Morikawa has collaborated with scholars based in Japan. Frequent co-authors include Shumpei Sakakibara, Shinjiro Odake, Kyoichi Kobashi, Leena Tuderman, Darwin J. Prockop, Terutoshi Kimura, M. Otani, Takanori Noda, Eisuke Munekata and Yoshihiro Masui. Their work appears in journals such as Biochemistry, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.